Ingemar holds a PhD in Physiology and Associate Professor in Toxicology from Uppsala University. He has a broad experience in business development and drug development from e.g. Astra Zeneca and Pharmacia and the financial industry. He is the co-founder of several life-science companies and holds several boards, mainly within Pharma, MedTech and Biotech.
Holdings in the company: 129,074 shares and 190,897 em- ployee warrants.
Independence: Ingemar is independent in relation to the company and is independent in relation to the Company’s largest shareholders.
Other Board assignments: Chairman of the Board in Miris Holding AB, Miris AB, Ilya Pharma AB, Arcede AB and Ingemar Kihlström AB. Board member in Healthinvest Partners AB, Attana AB, Lipum AB and G. Pettersson & Partners AB .